Primary Peritoneal Adenocarcinoma
NCI Definition: A rare adenocarcinoma that arises from the lining of the peritoneum. 
Primary peritoneal adenocarcinomas most frequently harbor alterations in TP53, KRAS, EPHB1, BRCA2, and BCOR .
TP53 Mutation, TP53 c.217-c.1178 Missense, TP53 Missense, TP53fs, and TP53 Exon 8 Mutation are the most common alterations in primary peritoneal adenocarcinoma .
There is 1 clinical trial for primary peritoneal adenocarcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains primary peritoneal adenocarcinoma as an inclusion criterion, 1 is phase 1 (1 open).
Nedisertib and pegylated liposomal doxorubicin are the most common interventions in primary peritoneal adenocarcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.